Palovarotene
CAS: 410528-02-8
Ref. 3D-FP167399
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Informação sobre produto
- 4-[(1E)-2-[5,6,7,8-Tetrahydro-5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-2-naphthalenyl]ethenyl]benzoic acid
- 4-{(1E)-2-[5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-5,6,7,8-tetrahydronaphthalen-2-yl]ethenyl}benzoicacid
- Benzoic acid, 4-[(1E)-2-[5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-3-(1H-pyrazol-1-ylmethyl)-2-naphthalenyl]ethenyl]-
- Clm 001
- Ipn 60120
- R 667
- Ro 3300074
- Sohonos
Palovarotene is a retinoid that is used in the treatment of bowel disease. It has been shown to bind to prostacyclin receptor and increase bone mass in the population. Palovarotene inhibits inflammatory bowel disease by inhibiting the production of inflammatory cytokines such as TNF-α, IL-1β, and IL-6. Palovarotene also has been shown to inhibit the activation of osteogenic genes and suppress the growth of autoimmune diseases. This drug has a variety of analogs with different ester linkages that have different pharmaceutical dosages. The symptoms for overdose include nausea, vomiting, hair loss, skin rash, fever, joint pain, and fatigue.
Propriedades químicas
Consulta técnica sobre: 3D-FP167399 Palovarotene
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.